|
National Stock Number(NSN): 6505-01-213-7113 (6505012137113, 012137113)
| NIIN: |
01-213-7113 |
Item Name: |
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION |
INC: |
49529
|
| FSC: |
6505
|
Assignment Date: |
Jul-29-1985 |
CRIT: |
X |
IIG: |
49529 |
| ISC: |
2 |
Date Standardized: |
Mar-09-1990 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.90.9260 |
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
KX |
ADPEC: |
0 |
RPDMRC: |
3 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
COLYTE |
04514
|
REED AND CARNRICK PHARMACEUTICALS DIV OF BLOCK DRUG CO INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
COLYTE |
17635
|
SCHWARZ PHARMA, INC. |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00021-0001-02 |
04514
|
REED AND CARNRICK PHARMACEUTICALS DIV OF BLOCK DRUG CO INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NDC00021-0001-02 |
17635
|
SCHWARZ PHARMA, INC. |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NDC51263-0001-02 |
28670
|
EDLAW PHARMACEUTICALS, INC. |
H |
5 |
9 |
4 |
KX |
|
B |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
Z |
M |
U |
1 |
A |
$6.42 |
PG |
|
C2201X- |
Jun-01-1993 |
H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$6.42 |
PG |
|
9L----- |
Oct-01-1992 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE ACTIVE INGREDIENT AND 227.00 GRAMS POLYETHYLENE GLYCOL, MORE THAN 1000 ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
PACKET |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
5 |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION |
| FEAT |
SPECIAL FEATURES |
FOR RECONSTITUTION TO 1 GALLON WITH DEIONIZED OR DISTILLED WATER TO A ISOSMOTIC SOLUTION |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
KX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
534 |
| Type of Cargo Code: |
Z |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MZ |
Air Dimension Code: |
A |
|